Magnus Groupinvites researchers, clinicians, academicians, immunologists, healthcare professionals, and industry experts to participate in the 2nd Edition of International Conference on Clinical Immunology, Allergy & Autoimmune Diseases.
📅 June 28–30, 2027 📍 Rome, Italy & Online 🎯 Theme:Advancing Immunology and Allergy Care through Research and Innovation
ICIAA 2027 will feature a wide range of scientific sessions covering the latest developments, innovations, research, and clinical advances in clinical immunology, allergy, asthma, autoimmune diseases, immune-mediated disorders, and related fields.
📝 Ready to present your research? Submit your abstract through the official ICIAA 2027 website.
🔬 Featured Scientific Session: Rheumatology and Systemic Autoimmune Disorders
This session will focus on emerging research, innovative diagnostic approaches, targeted therapies, immunomodulation, and advances in the management of systemic autoimmune and rheumatological disorders.
Whether you join in person or online, you’ll have the opportunity to connect with world-class researchers and healthcare professionals, share scientific insights, explore emerging developments, and build valuable international collaborations.
🔑 What to expect: Expert scientific presentations, research insights, engaging discussions, innovative approaches, and global networking opportunities.
Featured Scientific Session: Autoimmune and Autoinflammatory Diseases
The Autoimmune and Autoinflammatory Diseases session will provide an engaging platform to discuss emerging research, clinical advances, innovative treatments, and future directions in the understanding and management of these complex conditions.
Key Areas of Interest
Emerging mechanisms of autoimmune and autoinflammatory diseases
Advances in diagnosis and disease monitoring
Novel immunomodulatory and targeted therapies
Innovative approaches to patient care
Personalized and precision medicine
Translational and clinical research
Emerging therapeutic strategies and future perspectives
Why Participate in ICIAA 2027?
ICIAA 2027 offers an opportunity to connect with an international community of experts and exchange knowledge across clinical immunology, allergy, and autoimmune disease research.
Participants can:
🔬 Present their latest research and scientific findings 💡 Discover emerging developments and innovative approaches 🤝 Network with researchers, clinicians, and industry professionals 🌍 Build international collaborations 🚀 Contribute to discussions shaping the future of immunology and healthcare
📅 June 28–30, 2027 📍 Rome, Italy | Hybrid Event 🧬 Featured Session: Autoimmune and Autoinflammatory Diseases
✨ Conference Theme: “Advancing Immunology and Allergy Care through Research and Innovation”
Be part of ICIAA 2027 and explore how research, innovation, and collaboration are advancing the understanding and management of autoimmune and autoinflammatory diseases.
Taking place on June 28–30, 2027, in Rome, Italy, ICIAA 2027 will be conducted as a Hybrid Event, providing opportunities to participate both in person and virtually.
Featured Scientific Session: Clinical Immunology and Immune-Mediated Diseases
The Clinical Immunology and Immune-Mediated Diseases session will provide a platform for discussing recent developments and emerging perspectives in clinical immunology and immune-mediated disorders.
The session will focus on areas including:
Advances in clinical immunology research
Immune-mediated disease mechanisms and pathogenesis
Innovative diagnostic approaches
Emerging therapeutic strategies
Immunomodulatory and targeted therapies
Translational and clinical research
New approaches to disease management and patient care
Call for Speakers – Submit Your Abstract
Researchers, clinicians, scientists, academicians, and industry professionals are encouraged to share their latest research, clinical experiences, innovations, and scientific insights with an international audience.
Professionals interested in learning, networking, and connecting with experts in clinical immunology, allergy, and autoimmune diseases are invited to participate as delegates.
📅 Date: June 28–30, 2027 📍 Location: Rome, Italy 💻 Format: Hybrid Event 🧬 Featured Session: Clinical Immunology and Immune-Mediated Diseases ✨ Theme:“Advancing Immunology and Allergy Care through Research and Innovation”
ICIAA 2027 offers an excellent opportunity to present research, exchange knowledge, discover emerging developments, and build meaningful collaborations with professionals from across the global immunology and healthcare community.
Scheduled for June 28–30, 2027, in Rome, Italy, ICIAA 2027 will be held as a Hybrid Event, enabling participants to attend either in person or virtually from anywhere in the world.
Among the conference's distinguished scientific sessions is Allergy, Asthma and Hypersensitivity Disorders, which will bring together leading experts to discuss the latest discoveries, innovative treatment strategies, and clinical advancements transforming patient care.
Session Highlights
Emerging research in allergic diseases and immune-mediated disorders
Advances in asthma diagnosis and personalized treatment approaches
Mechanisms and management of hypersensitivity reactions
Novel therapeutic interventions and biologic therapies
Clinical case studies and evidence-based practices
Future directions in allergy and immunology research
This session provides an exceptional platform for knowledge exchange, interdisciplinary collaboration, and networking with renowned scientists and healthcare professionals from around the globe.
Whether you are a researcher presenting innovative findings, a clinician seeking the latest evidence-based practices, or an industry professional interested in emerging technologies, ICIAA 2027 offers valuable opportunities to learn, collaborate, and contribute to the future of immunology and allergy care.
Join ICIAA 2027 and be part of meaningful scientific discussions that are driving innovation in clinical immunology, allergy, asthma, and autoimmune disease research.
Theme:Advancing Immunology and Allergy Care through Research and Innovation
ICIAA 2027 will bring together distinguished researchers, clinicians, academicians, healthcare professionals, industry experts, and students from around the world to discuss the latest scientific discoveries, emerging technologies, and innovative approaches in Clinical Immunology, Allergy, and Autoimmune Diseases.
Abstract Submissions Are Now Open!
Researchers and professionals are invited to submit their original research, case studies, and scientific findings for presentation at ICIAA 2027. This is an excellent opportunity to present your work before an international audience, receive valuable feedback from experts, and contribute to meaningful scientific discussions.
Why Attend ICIAA 2027?
Present your latest research to a global scientific community.
Gain insights from internationally renowned keynote speakers and experts.
Network with researchers, clinicians, academicians, and industry leaders.
Explore the latest advancements in Clinical Immunology, Allergy, and Autoimmune Diseases.
Participate conveniently through our hybrid conference format.
Whether you are an experienced researcher, healthcare professional, industry representative, or an aspiring scientist, ICIAA 2027 offers an exceptional platform for knowledge exchange, collaboration, and professional growth.
Join us at ICIAA 2027 and become part of an international community dedicated to advancing immunology and allergy care through cutting-edge research and innovation. We look forward to welcoming speakers, delegates, researchers, clinicians, and healthcare professionals from across the globe to Rome, Italy.
.jpg)
